SISibel Aylin Ugur Iseri

Sibel Aylin Ugur Iseri

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Sibel Aylin Ugur Iseri has a total of 198 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Generalized Dystonia With Cervical Predominance in a Patient With a De Novo TCF20 Variant

    by Melisa Kilic, Petr Dusek, Ibrahim Kamaci, Bahar Gulmez, Gul Yalcin Cakmakli, Ersin Tan, Sibel Ugur Iseri, Zuhal Yapici

    TCF20 has been implicated in developmental delay and intellectual disability, with dystonia reported less frequently. We describe a woman in her early twenties with childhood‐onset learning difficulties, progressive dysarthria, tremor, and generalized dystonia with marked cervical predominance, associated with a de novo TCF20 frameshift variant identified by whole genome sequencing. Quantitative brain MRI demonstrated numerically increased globus pallidus susceptibility and reduced volume compared with controls, without clear evidence of iron accumulation. This case further supports generalized dystonia as a recognizable manifestation of TCF20 ‐related disorders and suggests a possible link between TCF20 dysfunction and globus pallidus involvement in dystonia pathophysiology.

  • Open Access

    XhetRel: a pipeline for X heterozygosity and relatedness analysis of sequencing data

    by Barış Salman, Nerses Bebek, Sibel Uğur İşEri

    Motivation: Verification of sample sex is an essential quality control step in next-generation sequencing studies, typically assessed from genomic data. Clustering individuals by X chromosome heterozygosity (Xhet) and incorporating relatedness estimates offers a practical first-pass screen for potential sex label errors, sample mix-ups, and pedigree inconsistencies. To better interpret Xhet based patterns, we further investigated the biological and technical origins using the 1000 Genomes Project dataset. Results: We developed XhetRel, a user-friendly workflow and notebook application that computes Xhet and performs relatedness estimation directly from VCF files. As a fully genotype-based approach, XhetRel enables both sex-based clustering and relatedness assessment as an initial quality control (QC) step in NGS. XhetRel serves groups without bioinformatics infrastructure, users requiring a browser-based QC tool, and workflow developers seeking a modular Nextflow component. Our investigation into the sources of Xhet variation highlighted important limitations in sequencing and variant-calling approaches. In particular, specific pseudogenes and gene clusters, such as SLC25A5 and the GAGE cluster, as recurrent contributors to misleading variant allele fractions. Availability and implementation: The source code and data are available at Figshare (doi: 10.6084/m9.figshare.28280414). XhetRel can be executed locally via Nextflow or accessed directly through the online Collab notebook at https://colab.research.google.com/drive/1ep69JvXLwK5ndHUQ8qIGTWvauzsTW9fi.

  • Missense variants in PKAN: insights from a multi-patient genetic analysis

    by Melisa Kılıç, Sevcan Mercan, Banu Özen Barut, Duruhan Meltem Demirkıran, Gül Yalçın Çakmaklı, Nihan Hande Akçakaya, Kanay Yararbaş, Omer Faruk Duzenli, Murat Gültekin, Zuhal Yapıcı, et al.

  • Open Access

    XhetRel: A Pipeline for X Heterozygosity and Relatedness Analysis in Sequencing Data

    by Barış Salman, Nerses Bebek, Sibel Uğur İşEri

    Motivation: Checking sample sex is one of the preliminary controls performed in genetic studies. Comparing multiple individuals and families in terms of sex and relatedness allows us to eliminate systematic errors in downstream analyses. While developing the pipeline we further delved into the origins of X heterozygosity by analysing the chromosome X variants from the 1000 Genomes Project. Result: We created an accessible and user-friendly notebook application for X heterozygosity analysis. XhetRel can serve as an initial quality control step in sequencing projects. Further investigating the source of X heterozygosity reveals the limitations of sequencing and variant calling methods in heterozygosity analysis. Our findings point to specific pseudogenes and gene clusters, such as SLC25A5 and GAGE cluster, as key contributors to erroneous variant allele fractions. Availability and implementation: Source code is available https://github.com/barslmn/XhetRel . Collab notebook can be accessed at https://colab.research.google.com/drive/1ep69JvXLwK5ndHUQ8qIGTWvauzsTW9fi .

  • Open Access

    Macrocephaly and Digital Anomalies Expand the Phenotypic Spectrum of PGAP2 Variants in Hyperphosphatasia with Impaired Intellectual Development Syndrome 3 (HPMRS3)

    by Seda Susgun, Afif Ben-Mahmoud, Franz Rüschendorf, Bonsu Ku, Syeda Iqra Hussain, Solveig Schulz, Oliver Puk, Saskia Biskup, Jonathan D. J. Labonne, Dilan Wellalage Don, et al.

    Glycosylphosphatidylinositols (GPIs) anchor over 150 proteins as GPI-anchored proteins (GPI-APs) with crucial roles in diverse biological processes. The highly conserved biosynthesis of GPI-APs involves precise steps with at least 21 genes, categorized as PIG and PGAP genes. Pathogenic variants in these genes are linked to human diseases, highlighting the importance of each biosynthesis step. PGAP2 stands out among these genes due to its association with an expanded clinical spectrum of neurodevelopmental disorder (NDD) phenotypes with biallelic pathogenic variants. We present four patients from two families, one consanguineous and the other nonconsanguineous, each displaying distinct clinical presentations, including intellectual disability, hyperphosphatasia, hearing impairment, and epilepsy, as well as craniofacial and digital anomalies. Genetic analyses revealed homozygous and novel compound heterozygous missense variants in PGAP2 in four affected individuals, confirming the molecular diagnosis of hyperphosphatasia with impaired intellectual development syndrome 3 (HPMRS3). Importantly, the three amino acids affected by missense variants exhibit complete conservation in 10 vertebrate species, illuminating their crucial role in the genes functionality. Protein modeling provided additional evidence for the pathogenicity of the three substitutions, demonstrating their detrimental impact on protein folding and putative protein-protein interactions, ultimately leading to impaired protein function. The four patients in our study displayed common phenotypic features, such as brachydactyly, camptodactyly, and syndactyly, which have not been previously documented in individuals with PGAP2 variants. Notably, the occurrence of macrocephaly in two affected brothers from a consanguineous Pakistani family represents a novel finding. These previously unreported digital anomalies, along with macrocephaly and the identification of novel compound heterozygous variants, contribute to the expansion of the phenotypic and genotypic spectrum of HPMRS3 associated with PGAP2 variants.


  • Novel Genetic Insights into Lateral Temporal Lobe Epilepsy: Findings from Whole Exome Sequencing

    by Sibel Uğur İşeri, Barış Salman, Yeşim Kesim, Seda Süsgün, Güneş Altıokka Uzun, Nermin Görkem, Nerses Bebek, Betül Baykan

    Lateral temporal lobe epilepsy (LTLE) is characterized by auditory auras and is often associated with genetic factors. Previous studies have identified various genes linked to LTLE, including LGI1. However, there remains a need to explore other genetic variants that contribute to the LTLE phenotype, particularly in the absence of LGI1 mutations. A cohort followed in our epilepsy center and diagnosed as LTLE with auditory aura was recruited to the study. We have performed whole exome sequencing data analysis of 19 patients using a two-step approach. In the first step, we have focused on six LTLE associated genes, namely LGI1, RELN, MICAL1, CNTNAP2, DEPDC5 and SCN1A. In the second step, the data was filtered against a list of epilepsy related genes. Our analysis identified novel variants in LTLE-associated genes, including RELN, SCN1A, and CNTNAP2, which confirmed previous findings. Importantly, for the first time, we identified a loss-of-function variation in the CHRNB2 gene that may be associated with the LTLE phenotype. Our study underscores the genetic heterogeneity of lateral temporal lobe epilepsy (LTLE) by identifying new genetic variants linked to the disorder. Notably, we propose that CHRNB2 is a novel gene associated with LTLE, thereby broadening the spectrum of known genetic contributors. This finding highlights the complexity of LTLE’s genetic landscape and suggests new pathways for future research and clinical application.


  • Two rare autosomal recessive neurological disorders identified by combined genetic approaches in a single consanguineous family with multiple offspring

    by Seda Susgun, Emrah Yucesan, Beyza Goncu, Sevde Hasanoglu Sayin, Umit Yasar Kina, Cemil Ozgul, Omer Faruk Duzenli, Ozcan Kocaturk, Mustafa Calik, Ugur Ozbek, et al.

    Introduction Neurodevelopmental disorders (NDDs) refer to a broad range of diseases including developmental delay, intellectual disability, epilepsy, autism spectrum disorders, and attention-deficit/hyperactivity disorder caused by dysfunctions in tightly controlled brain development. The genetic backgrounds of NDDs are quite heterogeneous; to date, recessive or dominant variations in numerous genes have been implicated. Herein, we present a large consanguineous family from Turkiye, who has been suffering from NDDs with two distinct clinical presentations. Methods and results Combined in-depth genetic approaches led us to identify a homozygous frameshift variant in NALCN related to NDD and expansion of dodecamer repeat in CSTB related to Unverricht-Lundborg disease (ULD). Additionally, we sought to functionally analyze the NALCN variant in terms of mRNA expression level and current alteration. We have both detected a decrease in the level of premature stop codon-bearing mRNA possibly through nonsense-mediated mRNA decay mechanism and also an increased current in patch-clamp recordings for the expressed truncated protein. Conclusion In conclusion, increased consanguinity may lead to the revealing of distinct rare neurogenetic diseases in a single family. Exome sequencing is generally considered the first-tier diagnostic test in individuals with NDD. Yet we underline the fact that customized approaches other than exome sequencing may be used as in the case of ULD to aid diagnosis and better genetic counseling.


  • Epilepsy Spectrum Associated with PRRT2 Variants: Case Presentations

    by Semı̇h Taşdelen, Gözde Yeşı̇l Sayın, Sı̇bel Aylı̇n Uğur İşerı̇, Nerses Bebek, Betül Baykan


  • Targeted resequencing reveals high-level mosaicism for a novel frameshift variant in WDR45 associated with beta-propeller protein-associated neurodegeneration

    by Seda Susgun, Mert Demirel, Gul Yalcin Cakmakli, Baris Salman, Kader K. Oguz, Bulent Elibol, Sibel Aylin Ugur Iseri, Zuhal Yapici

    Beta-propeller protein-associated neurodegeneration (BPAN) is a rare X-linked dominant neurodegenerative disease, which is characterized by iron accumulation in the basal ganglia. BPAN is associate...


  • Nörogenetik

    by Sibel Aylin Uğur İşEri İşEri

    Approximately 5 million individuals in Turkey have been afflicted with a rare disease. Difficulties experienced from diagnosis to treatment of rare diseases can only be solved with long-term, multidisciplinary and personalized approaches. Since neurological involvement is observed in at least half of all rare diseases, neurogenetic diseases constitute an important model in the context of rare disease research. The practical use of next-generation sequencing (NGS) technologies has made it possible to determine the heterogeneous genetic background of neurogenetic diseases. NGS oriented personalized and accessible genetic diagnosis has enabled characterization of de novo and mosaic variations, and demonstrated the genotype-phenotype relationships on a large scale. These milestones in the diagnosis of neurogenetic diseases have also been a light of hope for the treatment options. In particular, the rapid development of CRISPR-based gene editing technologies and high-efficiency gene transfer strategies in paralel with NGS have paved the way for new generation molecular treatments.